Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. (a foreign private issuer) was submitted on June 23, 2021. The document serves as a notice regarding the Company's 2021 Annual General Meeting of Shareholders, scheduled for August 3, 2021, at its offices in Rehovot, Israel. The filing incorporates the Notice of Meeting, Proxy Statement, and Proxy Card as exhibits.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses solely on the logistics and agenda for the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. It references the Proxy Statement (Exhibit 99.2) for details on proposals, corporate governance, and significant shareholders, but does not summarize that content within the main text of the Form 6-K.
Key Facts for Investor Verification
- Meeting Date: Tuesday, August 3, 2021, at 3:00 p.m. Israel time.
- Record Date: Shareholders of record as of the close of business on Tuesday, June 29, 2021, are entitled to vote.
- Location: Evogene's offices at 13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel.
- Exhibits: Detailed voting procedures and proposal backgrounds are located in Exhibits 99.1, 99.2, and 99.3 attached to the filing.
- Registration Statements: The contents of the exhibits are incorporated by reference into the Company's Form F-3 and Form S-8 registration statements.